The role of 17 beta-hydroxy steroid dehydrogenases

被引:308
作者
Mindnich, R [1 ]
Möller, G [1 ]
Adamski, J [1 ]
机构
[1] Natl Res Ctr Environm & Hlth, Inst Expt Genet, GSF, D-85764 Neuherberg, Germany
关键词
17 beta-hydroxysteroid dehydrogenase; estrogens; androgens; fatty acids; cancer; neuronal disease; genetics;
D O I
10.1016/j.mce.2003.12.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The biological activity of steroid hormones is regulated at the pre-receptor level by several enzymes including 17 beta-hydroxy steroid dehydrogenases (17 beta -HSD). The latter are present in many microorganisms, invertebrates and vertebrates. Dysfunctions in human 17 beta-hydroxysteroid dehydrogenases result in disorders of biology of reproduction and neuronal diseases, the enzymes are also involved in the pathogenesis of various cancers. 17 beta-hydroxysteroid dehydrogenases reveal a remarkable multifunctionality being able to modulate concentrations not only of steroids but as well of fatty and bile acids. Current knowledge on genetics, biochemistry and medical implications is presented in this review. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:7 / 20
页数:14
相关论文
共 188 条
[31]   Stiff-man syndrome:: identification of 17β-hydroxysteroid dehydrogenase type 4 as a novel 80-kDa antineuronal antigen [J].
Dinkel, K ;
Rickert, M ;
Möller, G ;
Adamski, J ;
Meinck, HM ;
Richter, W .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 130 (1-2) :184-193
[32]   Steroid dehydrogenase structures, mechanism of action, and disease [J].
Duax, WL ;
Ghosh, D ;
Pletnev, V .
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58, 2000, 58 :121-+
[33]   Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase [J].
Dufort, I ;
Rheault, P ;
Huang, XF ;
Soucy, P ;
Luu-The, V .
ENDOCRINOLOGY, 1999, 140 (02) :568-574
[34]   ENZYMES OF STEROID-HORMONE METABOLISM IN OVARIAN TISSUE OF TELEOSTS [J].
ECKSTEIN, B ;
AZOURY, R .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1979, 64 (03) :309-312
[35]  
Elo JP, 1996, INT J CANCER, V66, P37, DOI 10.1002/(SICI)1097-0215(19960328)66:1<37::AID-IJC7>3.3.CO
[36]  
2-Q
[37]   Oestrogen inactivation in the colon: analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer [J].
English, M. A. ;
Hughes, S. V. ;
Kane, K. F. ;
Langman, M. J. S. ;
Stewart, P. M. ;
Hewison, M. .
BRITISH JOURNAL OF CANCER, 2000, 83 (04) :550-558
[38]   Loss of estrogen inactivation in colonic cancer [J].
English, MA ;
Kane, KF ;
Cruickshank, N ;
Langman, MJS ;
Stewart, PM ;
Hewison, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :2080-2085
[39]   Ligand binding was acquired during evolution of nuclear receptors [J].
Escriva, H ;
Safi, R ;
Hanni, C ;
Langlois, MC ;
SaumitouLaprade, P ;
Stehelin, D ;
Capron, A ;
Pierce, R ;
Laudet, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6803-6808
[40]   Distribution of 17β-hydroxysteroid dehydrogenases in human osteoblast-like cells [J].
Feix, M ;
Wolf, L ;
Schweikert, HU .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 171 (1-2) :163-164